Figure 4From: Adverse health consequences in COPD patients with rapid decline in FEV1 - evidence from the UPLIFT trialSGRQ total score over four years by annualised RoD in post-bronchodilator FEV 1 . (A) tiotropium and (B) control groups. Abbreviations: SGRQ, St George's Respiratory Questionnaire; RoD, rate of decline; FEV1, forced expiratory volume in 1 second; ANOVA, analysis of variance.Back to article page